Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Bayer Aktiengesellschaft

Bayer Aktiengesellschaft Backs Crop Science Targets as Seed Pipeline Gains Momentum

Bayer Aktiengesellschaft (ETR:BAYN) executives said the company’s Crop Science division remains on track with a five-year plan centered on cost savings, margin expansion and a slate of product launches in seeds, traits and crop protection. Speaking at a BMO Capital Markets event, Rodrigo Santos, Pr

MarketBeat

Bayer Aktiengesellschaft Q1 Earnings Call Highlights

Bayer Aktiengesellschaft (ETR:BAYN) said its first-quarter results for 2026 were in line with expectations, with group sales rising 4% on a currency- and portfolio-adjusted basis to EUR 13.4 billion and core earnings per share increasing to EUR 2.71. Bill, speaking for Bayer management on the call,

MarketBeat

Top 4 Pharma Stocks to Consider This Month

With growing medical needs globally, R&D initiatives, and rapid adoption of emerging technologies like genAI, the pharma industry is well-poised to experience robust expansion. Thus, investors could consider buying top pharma stocks MEI Pharma (MEIP), Hypera (HYPMY), Aurinia Pharmaceuticals (AUPH), and Bayer (BAYRY) this month. Read on.

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

4 Cutting-Edge Pharma Stocks for Portfolio Diversification

The pharmaceutical industry is expected to grow rapidly due to increasing healthcare demand, technological advancements, and rising demand for innovative drugs. Therefore, for portfolio diversification, investors could consider buying fundamentally strong pharmaceutical stocks such as Bayer (BAYRY), Procaps Group (PROC), ACADIA Pharmaceuticals (ACAD), and Zoetis (ZTS). Read more.

StockNews.com

4 Strong Buys You'll Regret Missing out On

Although the stock market has been on a downtrend owing to multiple macroeconomic factors, such as rising inflation and the Fed's tighter monetary policy, investors could consider stocks that have the potential to stay resilient. The strong fundamentals of Alpha Metallurgical Resources (AMR), Bayer Aktiengesellschaft (BAYRY), Valhi (VHI), and Veritiv…

StockNews.com

Scoop up These 5 Dividend Stocks on Sale

The Federal Reserve’s aggressive interest hikes have fostered recession fears and significant volatility in the stock market. So, investors can consider adding quality dividend stocks Embotelladora Andina (AKO.B), Bristol-Myers Squibb (BMY), Bayer Aktiengesellschaft (BAYRY), A.P. Møller - Mærsk A/S (AMKBY), and Honda Motor (HMC) to their portfolios to ensure a…

StockNews.com

Investors Love Bayer, but the Courts Don’t – Buy, Sell, Hold?

Life sciences company Bayer (BAYRY) is currently facing a legal challenge concerning its Roundup. However, farmers have supported the company. On the other hand, despite the market volatility, the stock has been gaining in price. So, is the stock a Buy, Sell, or Hold now? Read on to find out….

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

3 Drug Manufacturers to Buy on the Pullback

The global pharmaceutical industry is expected to thrive with the lingering impact of COVID-19 and the evolving healthcare landscape. Given the industry’s solid prospects, the pullbacks in drug manufacturing stocks Merck & Co (MRK), Bristol-Myers Squibb (BMY), and Bayer Aktiengesellschaft (BAYRY) amid the broader market correction preset solid buying opportunity.…

StockNews.com

5 Safe and Cheap Stocks to Buy Amid the Market Volatility

Amid the heightened volatility in the market on concerns over rising inflation and a potential recession, we think fundamentally sound stocks Anthem (ANTM), Qiagen (QGEN), Bayer Aktiengesellschaft (BAYRY), Amdocs (DOX), and McKesson (MCK), which are currently trading at significant discounts to their peers, could be wise investments now. In addition…

StockNews.com

3 Pharmaceutical Stocks That Look Like Huge Bargains

Increasing investments in R&D and rising expenditure on healthcare are expected to bolster the pharmaceutical sector's growth. Therefore, we think the stocks of fundamentally sound pharmaceutical companies Bristol-Myers Squibb (BMY), Bayer Aktiengesellschaft (BAYRY), and Catalyst Pharmaceuticals, Inc. (CPRX), which are currently trading at huge discounts to their peers, could be…

StockNews.com

How Does the Pharmaceutical Industry Perform During Recessions?

The Fed’s aggressive interest rate hikes and high energy prices will likely fuel recessionary conditions. Moreover, the unexpected decline in GDP in the first quarter indicates a possible economic contraction. Amid such possibilities, the pharmaceutical industry could attract investors’ attention because of the inelastic demand for its products. Today, I…

StockNews.com

5 Cheap Value Stocks to Add to Your Portfolio

Despite the latest federal interest rate hikes, undervalued stocks with impressive financials are expected to deliver solid returns in the coming months. So, we think it could be wise to scoop up quality stocks Moderna (MRNA), Bayer (BAYRY), Henkel (HENKY), AGCO (AGCO), and Penske Automotive (PAG), which are currently trading…

StockNews.com

People

Dipanjan BanchurSince

722 stories

Bill Anderson

29 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Medical Pharmaceuticals

125 stories

HMC

108 stories

BristolMyers Squibb Company

95 stories

ZTS

78 stories

Medical – Pharmaceuticals

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.